KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesLong-Term Debt IssuancesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetShares Repurchased
Ratios

Quest Diagnostics (DGX) Leases (2019 - 2025)

Quest Diagnostics' Leases history spans 10 years, with the latest figure at $657.0 million for Q4 2025.

  • For Q4 2025, Leases rose 0.92% year-over-year to $657.0 million; the TTM value through Dec 2025 reached $657.0 million, up 0.92%, while the annual FY2025 figure was $657.0 million, 0.92% up from the prior year.
  • Leases for Q4 2025 was $657.0 million at Quest Diagnostics, up from $649.0 million in the prior quarter.
  • Across five years, Leases topped out at $661.0 million in Q3 2024 and bottomed at $579.0 million in Q1 2024.
  • The 5-year median for Leases is $605.0 million (2022), against an average of $615.6 million.
  • The largest annual shift saw Leases grew 17.19% in 2021 before it fell 5.0% in 2023.
  • A 5-year view of Leases shows it stood at $597.0 million in 2021, then decreased by 2.01% to $585.0 million in 2022, then rose by 2.91% to $602.0 million in 2023, then grew by 8.14% to $651.0 million in 2024, then grew by 0.92% to $657.0 million in 2025.
  • Per Business Quant, the three most recent readings for DGX's Leases are $657.0 million (Q4 2025), $649.0 million (Q3 2025), and $655.0 million (Q2 2025).